Gene: LMX1B
Official Full Name: LIM homeobox transcription factor 1 betaprovided by HGNC
Gene Summary: This gene encodes a member of LIM-homeodomain family of proteins containing two N-terminal zinc-binding LIM domains, 1 homeodomain, and a C-terminal glutamine-rich domain. It functions as a transcription factor, and is essential for the normal development of dorsal limb structures, the glomerular basement membrane, the anterior segment of the eye, and dopaminergic and serotonergic neurons. Mutations in this gene are associated with nail-patella syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36789 | LMX1B Knockout cell line (HCT 116) | Human | LMX1B | 1:2~1:4 | Negative | Online Inquiry |
KO36790 | LMX1B Knockout cell line (HEK293) | Human | LMX1B | 1:3~1:6 | Negative | Online Inquiry |
LMX1B Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of the LMX1B gene, which plays a crucial role in neural development and the regulation of dopaminergic neuron differentiation. These cell lines have been engineered through precise genetic modifications to disrupt the LMX1B gene, allowing researchers to investigate its contributions to various biological processes and disease states, particularly those related to neurodevelopmental disorders and Parkinson’s disease.
The key functions of this product center around its ability to simulate the absence of LMX1B, thus providing a valuable tool for examining molecular pathways that are influenced by this gene. The knockout mechanism effectively elucidates how the disruption of LMX1B affects cellular behaviors such as gene expression, cellular differentiation, and signal transduction. Researchers can employ these cell lines to perform functional assays, drug discovery, and molecular interaction studies, making it an indispensable tool in both basic research and translational science.
Scientifically, LMX1B Gene Knockout Cell Lines have wide-ranging applications in understanding neurodevelopmental disorders. By analyzing the phenotypic consequences of LMX1B deletion, scientists can uncover potential therapeutic targets and biomarkers. This is particularly pertinent in pharmacological research aimed at developing novel treatments for neurodegenerative diseases such as Parkinson's disease, where LMX1B dysfunction has been implicated.
The unique selling points of these knockout cell lines include their high specificity and reproducibility, allowing for robust experimental results that are often superior to traditional study models like primary neurons or animal models. Additionally, the ease of use in transfection and stable integration makes them accessible for a wide range of researchers, from molecular biologists to pharmacologists.
For researchers and clinicians focusing on neurobiology and genetic studies, LMX1B Gene Knockout Cell Lines offer a vital resource for advancing our understanding of gene function and uncovering new avenues for therapeutic intervention. With our commitment to quality and scientific excellence, our company remains at the forefront of providing high-caliber biological products that empower researchers to push the boundaries of discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.